SARCORONE, created in 1990 (Belgium), from 2466 sister brands and 17477 competing brands. SARCORONE is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York SARCORONE belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(SARCORONE)
over 5 years*
USD 161.71